摘要
目的探讨药品集中采购(以下简称“集采”)政策在平衡医疗、医药、医保费用,保证群众安全合理用药,促进医药行业健康发展等方面发挥的作用及存在的问题。方法对相关政策、文献、案例及其数据分析,多维度阐释政策对各利益相关方的影响及其反应。结果药品集采政策形成于我国经济市场化改革和医药卫生体制改革时期,它在促进药品供应保障制度建设的同时,推动了公立医院补偿机制和医疗服务价格改革,促进医保资金平衡和医药卫生治理体系现代化,现阶段集采存在政策落实、提质扩面问题,医疗服务价格调价缓慢,医保在平衡群众、医药、医疗发展和基金安全四方利益时难度加大,需要完善医保、医疗、医药统一高效的政策联动、管理协同机制,推行“价值医疗”。结论药品集采政策与医药、医疗、医保(以下简称“三医”)相关改革互为因果、相互协同,推动了“三医”治理体系和治理能力现代化进程。
Objective To explore the role and existing problems of centralized drug procurement policies in balancing medical,pharmaceutical,and medical insurance costs,ensuring safe and rational use of drugs by the public,and promoting the healthy development of the pharmaceutical industry.Method The relevant policies,literature,cases,and data were analyzed,and the impact and response of policies on various stakeholders and their reactions were interpreted from multiple dimensions.Result The policy of centralized drug procurement was formed during the period of China's economic marketization reform and medical and health system reform.While promoting the construction of the drug supply guarantee system,the policy has promoted the reform of the compensation mechanism of public hospitals and the medical service prices,promoted the balance of medical insurance funds and the modernization of the medical and health governance system.At present,centralized drug procurement has problems in policy implementation,quality improvement and expansion,slow adjustment of medical service prices,and increased difficulty in balancing the interests of the public,medicine,medical development,and fund security.It is necessary to improve the unified and efficient policy linkage and management coordination mechanism of medical insurance,healthcare,and medicine,and promote"value medicine".Conclusion The policy of centralized drug procurement and the reforms related to medicine,healthcare,and medical insurance are mutually causal and synergistic,promoting the modernization process of the governance system and governance capacity of the medicine,healthcare,and medical insurance.
作者
何洁
胡建新
李志优
袁斌
贾立明
HE Jie;HU Jianxin;LI Zhiyou;YUAN Bin;JIA Liming(Department of Pharmacy,Jiangxi Provincial People's Hospital(The First Affiliated Hospital of Nanchang Medical College),Nanchang 330006,Jiangxi Province,China;Jiangxi Provincial Medical Pricing and Procurement Service Center,Nanchang 330006,Jiangxi Province,China;Jiangxi Provincial Institute of Intelligent Health,Nanchang 330029,Jiangxi Province,China)
出处
《世界临床药物》
2025年第1期73-80,共8页
World Clinical Drug
基金
中国医药卫生文化协会《我国药品集中采购政策发展与比较研究》部分研究成果。
关键词
药品集中采购
医疗服务
医保
药品供应
centralized procurement of drugs
medical services
medical insurance
drug supply
